Related Experiment Video
Updated: Mar 27, 2026
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools
Aitor Esparza-Baquer1, Ibone Labiano1, Luis Bujanda2
1Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastián, Spain.
Abstract:
Cholangiopathies are the group of diseases targeting the bile duct epithelial cells (i.e. cholangiocytes). These disorders arise from different etiologies and represent a current diagnostic, prognostic and therapeutic challenge. Different molecular mechanisms participate in the development and progression of each type of biliary disease. However, microRNA deregulation is a common central event occurring in all of them that plays a key role in their pathogenesis. MicroRNAs are highly stable small non-coding RNAs present in cells, extracellular microvesicles and biofluids, representing valuable diagnostic tools and potential targets for therapy. In the following sections, the most novel and significant discoveries in this field are summarized and their potential clinical value is highlighted.
Insights
MicroRNA deregulation is central to cholangiopathies, diseases affecting bile duct cells. These small RNAs offer promising diagnostic and therapeutic strategies for biliary diseases.
Area of Science:
- Hepatology and Gastroenterology
- Molecular Biology
- Biochemistry
Background:
- Cholangiopathies encompass diverse diseases of bile duct epithelial cells (cholangiocytes).
- These disorders present significant diagnostic, prognostic, and therapeutic challenges.
- While etiologies vary, common molecular pathways underlie disease progression.
Purpose of the Study:
- To summarize recent discoveries in cholangiopathy pathogenesis.
- To highlight the role of microRNA deregulation in biliary diseases.
- To explore the clinical potential of microRNAs in diagnosing and treating cholangiopathies.
Main Methods:
- Review of current literature on cholangiopathies and microRNA research.
- Analysis of molecular mechanisms involving microRNA deregulation.
- Evaluation of microRNAs as biomarkers and therapeutic targets.
Main Results:
- MicroRNA deregulation is a unifying pathogenic mechanism across various cholangiopathies.
- MicroRNAs are stable molecules found in cells and biofluids.
- These non-coding RNAs demonstrate potential as diagnostic tools and therapeutic agents.
Conclusions:
- MicroRNA deregulation is a critical factor in the pathogenesis of cholangiopathies.
- MicroRNAs hold significant promise for clinical applications in biliary diseases.
- Further research into microRNA-based diagnostics and therapeutics is warranted.
